Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Johan, Courjon"'
Autor:
Claire Durand, Karine Risso, Michael Loschi, Nicolas Retur, Audrey Emery, Johan Courjon, Thomas Cluzeau, Michel Carles
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 13, Iss 1, Pp 1-9 (2024)
Abstract Background The 4th European Conference on Infections in Leukemia recommends early adaptation of empirical antibiotic therapy (EAT) for febrile neutropenia in stable patients. Objectives To assess the efficacy of an antimicrobial stewardship
Externí odkaz:
https://doaj.org/article/ef22d670c08d42cfaaf474e7ed7d02d8
Autor:
Karine Risso, Céline Michelangeli, Alice Gaudart, Mathieu Buscot, Emmanuel Chamorey, Johan Courjon, Michel Carles
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 280-284 (2023)
Objectives: Time-to-detection (TTD) in culture on liquid media is inversely correlated to bacillary load and should be a contributing factor for assessing tuberculosis transmission. We wanted to assess if TTD was a better alternative than smear statu
Externí odkaz:
https://doaj.org/article/f0cc6da24a874b0c9a4fb3090dde36c8
Autor:
Aurélien Dinh, Guillaume Béraud, Johan Courjon, Yann Le Goff, Nicolas Kader Ettahar, Matthieu Grégoire, Eric Senneville
Publikováno v:
Antibiotics, Vol 13, Iss 7, p 644 (2024)
Objectives. To identify the current practices with long half-life lipoglycopeptides (LGPs) and potential use/position of oritavancin. Results. Despite their indication being limited to skin and soft tissue infections (SSTIs), long half-life lipoglyco
Externí odkaz:
https://doaj.org/article/0471850e4ae0425eade340db80687ad2
Autor:
Thi Loi Dao, Van Thuan Hoang, Tran Duc Anh Ly, Amal Magmoun, Naomie Canard, Tassadit Drali, Florence Fenollar, Laetitia Ninove, Didier Raoult, Philippe Parola, Johan Courjon, Philippe Gautret
Publikováno v:
Travel Medicine and Infectious Disease, Vol 54, Iss , Pp 102609- (2023)
Externí odkaz:
https://doaj.org/article/39d87512a7f143d3a36af6f67f77da5c
Autor:
Matthieu Buscot, Marion Cremoni, Daisy Graça, Vesna Brglez, Johan Courjon, Jonathan Allouche, Maxime Teisseyre, Laurent Boyer, Jérôme Barrière, Emmanuel Chamorey, Michel Carles, Barbara Seitz-Polski
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCOVID-19 vaccines are expected to provide effective protection. However, emerging strains can cause breakthrough infection in vaccinated individuals. The immune response of vaccinated individuals who have experienced breakthrough infectio
Externí odkaz:
https://doaj.org/article/935271da6c644463ba17ecb7889e615d
Autor:
Johan Courjon, Julie Contenti, Elisa Demonchy, Jacques Levraut, Pascal Barbry, Géraldine Rios, Jean Dellamonica, David Chirio, Caroline Bonnefoy, Valérie Giordanengo, Michel Carles
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this area. A high incidence rate togethe
Externí odkaz:
https://doaj.org/article/ccfe3dbe8a484c0c8c3800949a624648
Autor:
Morgan Matt, Clara Duran, Johan Courjon, Romain Lotte, Vincent Le Moing, Boris Monnin, Patricia Pavese, Pascal Chavanet, Lydie Khatchatourian, Pierre Tattevin, Vincent Cattoir, Catherine Lechiche, Gabriella Illes, Flore Lacassin-Beller, Eric Senneville, Aurélien Dinh
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 341-345 (2021)
ABSTRACT: Objectives: Dalbavancin is a long-lasting lipoglycopeptide active against Gram-positive bacteria, especially methicillin-resistant staphylococci. Few data are available on dalbavancin use for treatment of prosthetic joint infections (PJIs).
Externí odkaz:
https://doaj.org/article/f033b31139be46a092ac8d6a9f27ed7f
Autor:
Marion Le Maréchal, Zoé Cavalli, Cécile Batailler, Jean-François Gonzalez, André Ferreira, Sébastien Lustig, Tristan Ferry, Johan Courjon
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Prosthetic joint infections (PJI) are one of the most serious complication of arthroplasty. The management of PJI needs a multidisciplinary collaboration between orthopaedic surgeon, infectious disease specialist and microbiologis
Externí odkaz:
https://doaj.org/article/8df8241ddbbe42e3a05df9cf7feaae42
Autor:
Alexandra Audemard-Verger, Amélie Le Gouge, Vincent Pestre, Johan Courjon, Vincent Langlois, Marc-Olivier Vareil, Mathilde Devaux, Boris Bienvenu, Vincent Leroy, Radjiv Goulabchand, Léa Colombain, Adrien Bigot, Thomas Guimard, Youcef Douadi, Geoffrey Urbanski, Jean François Faucher, Laurence Maulin, Bertrand Lioger, Jean-Philippe Talarmin, Matthieu Groh, Joseph Emmerich, Sophie Deriaz, Nicole Ferreira-Maldent, Ann-Rose Cook, Céline Lengellé, Hélène Bourgoin, Arsène Mekinian, Achille Aouba, François Maillot, Agnès Caille
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Objective We aimed to investigate whether anakinra, an interleukin-1receptor inhibitor, could improve outcome in moderate COVID-19 patients. Methods In this controlled, open-label trial, we enrolled adults with COVID-19 requiring oxygen. We randomly
Externí odkaz:
https://doaj.org/article/a654617adbad4e2e95fef1473f11dac2
Autor:
Marion Louvois, Loïc Simon, Christelle Pomares, Pierre-Yves Jeandel, Elisa Demonchy, Michel Carles, Pascal Delaunay, Johan Courjon
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Malaria is still an endemic disease in Africa, with many imported cases in Europe. The standard treatment is intravenous artesunate for severe malaria and oral artemisinin-based combination therapy (ACT) for uncomplicated malaria. Delayed hemolytic a
Externí odkaz:
https://doaj.org/article/1682c38ede184dcba5bc965cbba2d350